Motherson To Acquire German G+S

Delhi based Motherson Sumi Systems Ltd has reached an agreement with German insolvency administrators to acquire a running plastics injection molding company, G+S Kunststofftechnik Gmbh (G+S), located near Stuttgart in Germany.

Centre Plans Guideline For Uniform Action Against NSQ Medical Devices

The Central Drugs Standard Control Organisation (CDSCO) has decided to prepare a guideline for uniform action against the manufacture of not of standard quality (NSQ) medical devices, diagnostic reagents, diagnostic kits etc. The guideline would prescribe the exact procedures to be followed and action to be taken against the manufacturers by every state drug controller.

DTAB Nod On Medical Device Control On August 2

The Central Government is likely to bring in amendments to Drugs and Cosmetic Rules within three months to arm the Central Drugs Standard Control Organisation (CDSCO) to regulate the entire range of medical devices manufactured or marketed in the country.

Care To Implant New Cardiac Device In 100 Patients As Part Of Global Study

The Hyderabad based Care Hospitals will soon start screening patients suffering from atrial fibrillation, a condition in which the upper chamber of the heart beat becomes too fast leading to blood clots, for implanting 'Watchman' device among 100 patients free, as part of a worldwide study.

NGO Launches Nationwide Campaign Against Unapproved Medical Devices

Public Response Against Helplessness and Action for Redressal (PRAHAR), a Delhi based non-governmental organisation, has launched a multi-city campaign 'Making Cardiac Care Fair' against implant of 'life threatening illegal medical devices' on unsuspecting patients.

Relisys To Commission New Catheter Facility By Early 2005

Relisys Medical Devices will soon commission its catheter manufacturing facility at Ibrahimpatnam near Hyderabad. The facility is expected to go on stream by December 2005 and the trial runs are likely to start from January 2006.

Relisys To Initiate Int'l Registry For New Version DES

The Hyderabad based Relisys Medical Devices is initiating an international multi-centre registry to create data on its new version of Drug Eluting Stent (DES). The new version consists of a cobalt-chromium stent, coated with porus carbon-carbon nano-matrix containing the active drug, which eliminates the use of polymer, thus reducing the tissue inflammation and reaction.